Crowdonomics
SharpMed

Reg CF · Common Stock · May 2024

ClosedReached targetReg CFCommon Equity
via Republic · last checked Oct 8, 2026View campaign
Raised
$212.2K / $1.2M max
18% of ceiling · target hit day 6
Investors
267
$797.2 avg
Valuation
—
—

Raised over time

Cumulative raisedInvestors
$213K$106K$0
2651330
May 27, 2024 · openedNov 16, 2024 · last reading
Target ($50K) hit — Jun 2, 2024, day 6Deadline Nov 15, 2024

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via Republic, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$2.7M
FY2022
$0
−$1.0M
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$2,702,404
-$1,041,555
Taxes paid
$0
$0
Balance sheet
Cash
$21,882
$73,268
Accounts receivable
$0
$0
Total assets
$531,945
$312,773
Short-term debt
$3,439,211
$3,846,594
Long-term debt
$2,436,533
$2,436,533
Total liabilities
$5,875,744
$6,283,127
Other
Headcount
—
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Aug 5, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Price / share$2.00
Shares offered25,000

Offering details

Target$50,000
Max$1,200,000
Min investment$100
OpenedMay 27, 2024
DeadlineNov 15, 2024
ClosedNov 15, 2024
Days active172

Links & provenance

Source: Manual
0001999382-24-000001
Last synced Aug 19, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.